Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
Public ClinicalTrials.gov record NCT05838625. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, 16-week Study to Evaluate the Efficacy and Safety of Two Prescription Digital Therapeutics as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms of schizophrenia in late adolescents and adults.
Study identification
- NCT ID
- NCT05838625
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 464 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2023 (Actual)
- Primary completion
- Jun 20, 2025 (Actual)
- Completion
- Jul 23, 2025 (Actual)
- Last update posted
- Jun 12, 2026
2023 – 2025
United States locations
- U.S. sites
- 54
- U.S. states
- 22
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational center | Chandler | Arizona | 85226 | — |
| Investigational center | Phoenix | Arizona | 85012 | — |
| Investigational center | Anaheim | California | 92805 | — |
| Investigational center | Culver City | California | 90230 | — |
| Investigational center | Garden Grove | California | 92845 | — |
| Investigational center | La Habra | California | 90631 | — |
| Investigational center | Long Beach | California | 90807 | — |
| Investigational center | Los Angeles | California | 90025 | — |
| Investigational center | Newport Beach | California | 92660 | — |
| Investigational center | Oceanside | California | 92056 | — |
| Investigational center | Orange | California | 92868 | — |
| Investigational center | San Bernardino | California | 92408 | — |
| Investigational center | Torrance | California | 90504 | — |
| Investigational center | Cromwell | Connecticut | 06416 | — |
| Investigational center | Hartford | Connecticut | 06116 | — |
| Investigational center | Hialeah | Florida | 33016 | — |
| Investigational center | Largo | Florida | 33777 | — |
| Investigational center | Miami | Florida | 33156 | — |
| Investigational center | Miami Lakes | Florida | 33014 | — |
| Investigational center | Orlando | Florida | 32803 | — |
| Investigational center | West Palm Beach | Florida | 33407 | — |
| Investigational center | Atlanta | Georgia | 30338 | — |
| Investigational center | Augusta | Georgia | 30912 | — |
| Investigational center | Chicago | Illinois | 60611 | — |
| Investigational center | Springfield | Illinois | 77030 | — |
| Investigational center | Warrenville | Illinois | 60555 | — |
| Investigational center | Marrero | Louisiana | 70072 | — |
| Investigational center | Baltimore | Maryland | 21204 | — |
| Investigational center | Boston | Massachusetts | 02131 | — |
| Investigational center | Flowood | Mississippi | 39232 | — |
| Investigational center | St Louis | Missouri | 63141 | — |
| Investigational center | Omaha | Nebraska | 68144 | — |
| Investigational center | Las Vegas | Nevada | 89124 | — |
| Investigational center | Marlton | New Jersey | 08054 | — |
| Investigational center | Cedarhurst | New York | 11516 | — |
| Investigational center | Glen Oaks | New York | 11004 | — |
| Click Therapeutics | New York | New York | 10013 | — |
| Investigational center | New York | New York | 10027 | — |
| Investigational center | Rochester | New York | 14623 | — |
| Investigational center | Charlotte | North Carolina | 27608 | — |
| Investigational center | Beachwood | Ohio | 44122 | — |
| Investigational center | Cincinnati | Ohio | 45267 | — |
| Investigational center | Columbus | Ohio | 43210 | — |
| Investigational center | Oklahoma City | Oklahoma | 73116 | — |
| Investigational center | State College | Pennsylvania | 16801 | — |
| Investigational center | Charleston | South Carolina | 29425 | — |
| Investigational center | Austin | Texas | 78752 | — |
| Investigational center | Fort Worth | Texas | 76104 | — |
| Investigational center | Houston | Texas | 77030 | — |
| Investigational center | Irving | Texas | 75062 | — |
| Investigational center | Mesquite | Texas | 75149 | — |
| Investigational center | Plano | Texas | 75093 | — |
| Investigational center | Salt Lake City | Utah | 84105 | — |
| Investigational center | St. George | Utah | 84770 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05838625, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05838625 live on ClinicalTrials.gov.